Euroapi Shares Nosedive As It Takes Axe To 2023 Guidance Late In The Year
18-Month Old Firm Sees Customer Destocking For APIs, Biotech ‘Funding Crisis’
Investors voted with their feet after Sanofi’s spunoff standalone API manufacturing and CDMO business announced a radical downshift in expectations for 2023, while pausing longer term targets.
